[HTML][HTML] DOACs in the anticoagulation of mechanical valves: A systematic review and future perspectives
T Langenaeken, A Vanoppen, F Janssens… - Journal of Clinical …, 2023 - mdpi.com
Valvular heart disease is a common disease often necessitating valve replacement.
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives
T Langenaeken, A Vanoppen… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Valvular heart disease is a common disease often necessitating valve replacement.
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives
T Langenaeken, A Vanoppen… - Journal of Clinical …, 2023 - search.proquest.com
Valvular heart disease is a common disease often necessitating valve replacement.
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives
T Langenaeken, A Vanoppen, F Janssens… - Journal Of Clinical …, 2023 - lirias.kuleuven.be
UNLABELLED: Valvular heart disease is a common disease often necessitating valve
replacement. Mechanical heart valves (MHVs) are often used in younger patients because …
replacement. Mechanical heart valves (MHVs) are often used in younger patients because …
DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives.
T Langenaeken, A Vanoppen, F Janssens… - Journal of Clinical …, 2023 - europepmc.org
Conclusions DOAC use in MHVs has been halted due to the failure of both dabigatran and
apixaban in two major clinical trials. However, rivaroxaban was successful in two small …
apixaban in two major clinical trials. However, rivaroxaban was successful in two small …
[HTML][HTML] DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives
T Langenaeken, A Vanoppen, F Janssens… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Valvular heart disease is a common disease often necessitating valve replacement.
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives.
T Langenaeken, A Vanoppen… - Journal of Clinical …, 2023 - search.ebscohost.com
Valvular heart disease is a common disease often necessitating valve replacement.
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives.
T Langenaeken, A Vanoppen, F Janssens… - Journal of Clinical …, 2023 - go.gale.com
Valvular heart disease is a common disease often necessitating valve replacement.
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
Mechanical heart valves (MHVs) are often used in younger patients because of their longer …
DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives.
T Langenaeken, A Vanoppen, F Janssens… - Journal of Clinical …, 2023 - europepmc.org
Conclusions DOAC use in MHVs has been halted due to the failure of both dabigatran and
apixaban in two major clinical trials. However, rivaroxaban was successful in two small …
apixaban in two major clinical trials. However, rivaroxaban was successful in two small …